Last Close
15.41 $
Jul 6, 26
Market Cap
965.7 M $
Q1 2026 (TTM)
52-Week Range
%-35.7
%74.3
-0.65
-0.56
%-55.6
-%64.9
1M
+15.3%
3M
+3.1%
6M
+12.1%
YTD
+11.7%
1Y
-37.0%
3Y
+26.2%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
JANX last closed at 15.41 $ (Jul 6, 26). Price data is refreshed after every trading day.
Janux Therapeutics Inc (JANX) has a market capitalization of approximately 965.7 M $ as of the latest reported period.
Key peers of Janux Therapeutics Inc include Mesoblast Ltd, TELIX Pharmaceuticals Ltd, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S., CSL Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.